Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Statistical Methods in Medical Research
|
June 3, 2017
Propensity score analysis with partially observed covariates: How should multiple imputation be used?
Clémence Leyrat, Shaun R Seaman, Ian R White, et al.
BMJ (Clinical Research Ed.)
|
June 16, 2021
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Tommy Nyberg, Katherine A Twohig, Ross J Harris, et al.
International Journal of Epidemiology
|
November 1, 2011
A synthesis of convenience survey and other data to estimate undiagnosed HIV infection among men who have sex with men in England and Wales
Kate Walker, Shaun R Seaman, Daniela De Angelis, et al.
JAMA Network Open
|
June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
Claire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Addiction (Abingdon, England)
|
June 2, 2026
Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020
Ruyu Yan, Jeong Eun Min, Megan Kurz, et al.
The Lancet. Infectious Diseases
|
August 30, 2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A Twohig, Tommy Nyberg, Asad Zaidi, et al.
The Journal of Infectious Diseases
|
February 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages
Tommy Nyberg, Katie Harman, Asad Zaidi, et al.
Addiction (Abingdon, England)
|
August 31, 2025
Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada
Megan Kurz, Brenda Carolina Guerra-Alejos, Jeong Eun Min, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews
|
May 7, 1999
Regulating and assessing risks of cholinesterase-inhibiting pesticides: divergent approaches and interpretations
L L Carlock, W L Chen, E B Gordon, et al.
JAMA
|
October 17, 2024
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
Bohdan Nosyk, Jeong Eun Min, Fahmida Homayra, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Statistical Methods in Medical Research
|
June 3, 2017
Propensity score analysis with partially observed covariates: How should multiple imputation be used?
Clémence Leyrat, Shaun R Seaman, Ian R White, et al.
BMJ (Clinical Research Ed.)
|
June 16, 2021
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Tommy Nyberg, Katherine A Twohig, Ross J Harris, et al.
International Journal of Epidemiology
|
November 1, 2011
A synthesis of convenience survey and other data to estimate undiagnosed HIV infection among men who have sex with men in England and Wales
Kate Walker, Shaun R Seaman, Daniela De Angelis, et al.
JAMA Network Open
|
June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
Claire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Addiction (Abingdon, England)
|
June 2, 2026
Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020
Ruyu Yan, Jeong Eun Min, Megan Kurz, et al.
The Lancet. Infectious Diseases
|
August 30, 2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A Twohig, Tommy Nyberg, Asad Zaidi, et al.
The Journal of Infectious Diseases
|
February 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages
Tommy Nyberg, Katie Harman, Asad Zaidi, et al.
Addiction (Abingdon, England)
|
August 31, 2025
Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada
Megan Kurz, Brenda Carolina Guerra-Alejos, Jeong Eun Min, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews
|
May 7, 1999
Regulating and assessing risks of cholinesterase-inhibiting pesticides: divergent approaches and interpretations
L L Carlock, W L Chen, E B Gordon, et al.
JAMA
|
October 17, 2024
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
Bohdan Nosyk, Jeong Eun Min, Fahmida Homayra, et al.
Page
of 11